Turning immune cells into cancer-fighting ninjas

What if your own immune cells could be trained to fight off cancer? That's the idea behind cancer immunotherapy. Dr. Steven Rosenberg's group at the National Cancer Institute uses RetroNectin reagent to introduce T-cell receptor genes recognizing specific cancer antigens into a patient's own lymphocytes. These engineered cells are then returned to the patient, where they specifically target cancer cells expressing the antigen. That's GOOD Science!

Explore how we support research focused on improving human health